Status: current, Not sufficiently defined by necessary conditions definition status. Date: 25-Nov 2020. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1687741000001111 | Mometasone + Glycopyrronium bromide + Indacaterol | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 1687751000001114 | Mometasone + Glycopyrronium bromide + Indacaterol (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Mometasone + Glycopyrronium bromide + Indacaterol | Is a | Virtual therapeutic moiety | true | Inferred relationship | Existential restriction modifier | ||
| Mometasone + Glycopyrronium bromide + Indacaterol | Is a | Product containing mometasone | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Generic Enerzair Breezhaler 114micrograms/dose / 46micrograms/dose / 136micrograms/dose inhalation powder capsules with device | Is a | True | Mometasone + Glycopyrronium bromide + Indacaterol | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR